Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Drug And Gene Delivery Devices Market Revenue Growth On Track For A 8.6% CAGR Through 2030
The drug and gene delivery devices market has experienced robust expansion in recent years. This market is projected to grow from $0.67 billion in 2025 to $0.73 billion in 2026, at a compound annual growth rate (CAGR) of 8.9%. The historic period’s growth can be attributed to several factors, including the limited availability of advanced delivery devices, a reliance on conventional administration routes, the early stages of gene therapy development, a growing biologics pipeline, and increasing investment in research collaborations.
The market for drug and gene delivery devices is projected to experience substantial expansion in the coming years. It is anticipated to reach $1.01 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This expansion during the projection period stems from innovations in viral and non-viral vector technologies, the broadening scope of personalized medicine and gene therapy applications, a rise in regulatory approvals for novel delivery methods, growing acceptance of nanomedicine and LNPs, and the incorporation of digital monitoring and intelligent delivery platforms. Key developments predicted for the forecast timeframe encompass the proliferation of targeted drug and gene therapies, increased uptake of nanoparticle-based delivery mechanisms, a surge in the application of viral vectors for gene therapy, the broadening availability of injectable and non-invasive delivery techniques, and an emphasis on personalized medicine and controlled release technologies.
Get A Free Sample Report With In-Depth Market Insights:
Drug And Gene Delivery Devices Market Expansion Drivers: What’s Shaping Future Growth?
The growing acceptance of gene therapy is anticipated to boost expansion in the drug and gene delivery devices market. This medical approach entails inserting, removing, or modifying genetic material within a patient’s cells to manage or prevent illnesses. Demand for gene therapy is escalating as it holds the promise to rectify genetic ailments and chronic conditions by addressing their underlying causes, presenting revolutionary treatment alternatives where traditional methods prove inadequate. Drug and gene delivery devices play a crucial role in gene therapy by enabling accurate targeting and regulated release of therapeutic genes, thereby improving treatment effectiveness. As an illustration, in January 2025, the American Society of Gene & Cell Therapy, a US-based non-profit organization, reported that during Q4 2024, the count of pre-registration gene therapy programs saw its most significant rise in over a year, increasing by 83% relative to Q3 2024. Consequently, the heightened embrace of gene therapy is fueling the development of the drug and gene delivery devices market.
Drug And Gene Delivery Devices Market Segment Outlook: Which Categories Are Growing Fastest?
The drug and gene delivery devices market covered in this report is segmented –
1) By Vector: Viral, Non-viral
2) By Method: In Situ, Ex Vivo
3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
Subsegments:
1) By Viral: Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors
2) By Non-Viral: Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels.
Drug And Gene Delivery Devices Market Strategic Trends: What Defines The Next Growth Phase?
Major companies operating in the drug and gene delivery devices market are concentrating on developing advanced products, such as artificial intelligence (AI) technology, to gain a competitive advantage. Artificial intelligence (AI) technology in drug delivery refers to the application of AI techniques and algorithms to improve the efficiency, precision, and effectiveness of drug delivery systems. For instance, in December 2023, Envoya Inc., a US-based developer of polymer-based nanoparticles for targeted delivery, launched an innovative gene therapy drug delivery platform. This platform combines biopolymer-nanoparticles with artificial intelligence (AI) to address significant limitations in current gene therapy technologies, such as viral vectors and lipid nanoparticles. The platform aims to overcome the limitations of existing gene therapy delivery technologies, which have been restricted by safety concerns, limited payload capacities, and limited tissue targeting.
Drug And Gene Delivery Devices Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the drug and gene delivery devices market are Medtronic plc, Moderna Inc., Halozyme Therapeutics Inc., Uniqure NV, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics, Pfizer Inc., Novartis AG, Becton Dickinson and Company, Shanghai Sunway Biotech Co Ltd, Epeius Biotechnologies Corporation, SiBiono GeneTech Co Ltd, F Hoffmann-La Roche Ltd, Baxter International, B Braun Melsungen, Terumo Corporation, ICU Medical, Stevanato Group, Gerresheimer AG, Ypsomed, SHL Medical
View The Full Drug And Gene Delivery Devices Market Report:
Drug And Gene Delivery Devices Market Geographic Spread And Regional Opportunities
North America was the largest region in the drug and gene delivery devices market in 2025. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
